- Home
- PGZ vs FORA Comparison
PGZ vs FORA Comparison
Compare PGZ & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGZ | FORA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.3M | 67.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PGZ | FORA |
|---|---|---|
| Price | $9.90 | $2.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.3K | ★ 62.6K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 12.26% | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $9.32 | $1.64 |
| 52 Week High | $10.64 | $2.71 |
Technical Indicators
Market Signals| Indicator | PGZ | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 64.06 |
| Support Level | $9.60 | $2.05 |
| Resistance Level | $10.58 | $2.20 |
| Average True Range (ATR) | 0.11 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 77.50 | 66.67 |
Price Performance
Historical ComparisonAbout PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Singapore, South Korea, British Virgin Islands and more.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.